GE reveals new company names as it approaches historic split

GE reveals new company names as it approaches historic split


People visit the General Electric stand during the China International Import Expo (CIIE) at the National Exhibition and Convention Center on November 7, 2018 in Shanghai, China.

VCG | Getty Images

General Electric on Monday revealed the names of the three distinct companies that will result from the conglomerate’s historic split: GE HealthCare, GE Aerospace and GE Vernova.

GE HealthCare will encompass the company’s health services branch and will be listed on the Nasdaq under the symbol “GEHC,” the company said in a release. That spin-off is expected to be completed early next year.

GE Aerospace will encompass the company’s aviation branch, which includes a fleet of 39,400 commercial and 26,200 military aircraft. The aerospace offshoot will also own the GE trademark, which it can license out to the other divisions.

The company’s renewable energy businesses will fall under the name GE Vernova — a title the company said is “a combination of ‘ver,’ derived from ‘verde’ and ‘verdant’ to signal the greens and blues of the Earth, and ‘nova,’ from the Latin ‘novus,’ or ‘new,’ reflecting a new and innovative era of lower carbon energy that GE Vernova will help deliver.”

GE maintains an installed base of 7,000 gas turbines and 400 gigawatts of renewable energy equipment. The spin-off of that business is expected to be completed in early 2024.

“Today marks a key milestone in GE’s plan to become three independent, laser-focused companies,” Chairman and CEO Larry Culp said in a statement. “Leveraging GE’s multi-billion-dollar global brand gives us a competitive advantage in our end markets, allowing these businesses to win in the future.”

Shares of GE were up about 2% in morning trading Monday amid broader market gains. The stock is down roughly 30% so far in 2022.



Source

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to  billion
Health

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to $12 billion

A startup widely known as “ChatGPT for doctors” raised a new funding round that values the company at $12 billion. OpenEvidence, based in Miami, Florida, closed a $250 million financing, led by Thrive Capital and DST, the company told CNBC. The startup first raised outside capital in February, when it reeled in $75 million from […]

Read More
Another alliance of health care and AI signals why pharma stocks should be back in favor
Health

Another alliance of health care and AI signals why pharma stocks should be back in favor

Bristol Myers Squibb and Microsoft ‘s new partnership aimed at accelerating early detection of lung cancer marks the latest way health care and artificial intelligence are rapidly intersecting. Bristol Myers said on Tuesday it will work with Microsoft’s AI-powered radiology platform to develop and launch imaging algorithms. These new tools, which can be used to […]

Read More
Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry
Health

Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry

US President Donald Trump arrives for an announcement in the Roosevelt Room of the White House in Washington, DC, US, on Friday, Dec. 19, 2025. Will Oliver | Bloomberg | Getty Images Drug pricing. Looming patent cliffs. Dealmaking. The first year of Trump 2.0. Those are among the themes that dominated conversations last week as drugmakers […]

Read More